Jose Milei

José Milei is Ph.D., M.D., Professor of Internal Medicine and Director of the Institute of Cardiological Investigations (ININCA) “Prof. Dr. A. C. Taquini” at the University of Buenos Aires (UBA) and the National Research Council for Science and Technology (CONICET), Argentina. His thesis about the effects of isoproterenol on myocardium was published in Am Heart J in 1976 and has been extensively cited as well as his investigations in the ’80 in NIH, National Heart, Lung and Blood Institute, USA under the guidance of his mentor, Victor Ferrans. Member of the Argentine Society of Cardiology from 1975, has developed an extensive societary activity. Professor Milei is Chairman of the Module of Cardiology and Hypertension at the Argentine Medical Association devoted to South American general practitioners´ training. His research on Chagas’ cardiomyopathy substantially contributed to the knowledge of its pathophysiology and his work on early atherosclerotic lesions helped set up the basis for the importance of intimal thickenings in plaque genesis. He has authored over 140 papers in peer review journals, 4 books and over 10 invited chapters in books of cardiology. He is scientific advisor to University of Buenos Aires and Director of the Doctoral Department of the Northwest University in Argentina. His treaty on Chagas’ disease is a referent book in the last 20 years.

2books edited

4chapters authored

Latest work with IntechOpen by Jose Milei

The disease of the heart muscle may occur secondarily to common diseases, such as ischemic, hypertensive and valvular, among others. However, there is a group of conditions with intrinsic myocardial involvement from gene or multifactorial etiology, and high morbidity and mortality that represent a diagnostic and therapeutic challenge for the physician. The book is focused on these cardiomyopathies, its features, its pathophysiology and its relation to sudden death. Mention is made also on general aspects, like ecocardiographic findings and myocardial contractile reserve, specific as pathophysiology and molecular mechanisms and cardiomyopathies in special populations. Special attention was deserved to cardiomyopathies in pediatrics, diabetic patients and women, as well as to the cases of chronic heart failure and dilated cardiomyopathy.

Go to the book